Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL

Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The...

GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL ( Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The Netherlands )

Real world evidence on the use of antibody drug conjugates in peripheral T-cell...

Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut...

Real world evidence on the use of antibody drug conjugates in peripheral T-cell lymphoma ( Prof Ali Bazarbachi - American University of Beirut-Medical Center, Beirut, Lebanon )

Palliative Care: Industry and Academia – Tensions and Opportunities

Dr Jim Cleary - IU Simon Cancer Center, Indianapolis, USA

Palliative Care: Industry and Academia – Tensions and Opportunities ( Dr Jim Cleary - IU Simon Cancer Center, Indianapolis, USA )

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC...

Prof Andrea Filippi - University of Pavia, Pavia, Italy

Durvalumab following radiotherapy in patients with unresectable, stage 3 NSCLC ineligible for chemotherapy ( Prof Andrea Filippi - University of Pavia, Pavia, Italy )

OncoAlert and ecancer weekly roundup for March 01 - 06, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly roundup for March 01 - 06, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Reduced intensity allogeneic HSCT to hypomethylating therapy or best supportive...

Dr Ryotaro Nakamura - City of Hope, California, USA

Reduced intensity allogeneic HSCT to hypomethylating therapy or best supportive care in older patients with advanced MDS ( Dr Ryotaro Nakamura - City of Hope, California, USA )

Haematology updates from SIOG 2020

Dr Tanya Wildes - SIOG Science & Education Committee Chair

Haematology updates from SIOG 2020 ( Dr Tanya Wildes - SIOG Science & Education Committee Chair )

Guidelines to ensure high quality palliative care

Judy Knudson, PA-C - University of Colorado, Denver, USA

Guidelines to ensure high quality palliative care ( Judy Knudson, PA-C - University of Colorado, Denver, USA )

OncoAlert Colloquium Day 2: Lung cancer and SIOG

Dr Willers, Dr Sequist, Dr Liu, Dr Peters, Dr Kanesvaran, Ms Feldman, Dr...

OncoAlert Colloquium Day 2: Lung cancer and SIOG ( Dr Willers, Dr Sequist, Dr Liu, Dr Peters, Dr Kanesvaran, Ms Feldman, Dr Battisti )

OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma

Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen

OncoAlert Colloquium Day 4: Gynae-oncology, lymphoma, sarcoma and melanoma ( Dr Dizon, Dr Trent, Dr Cordoba, Dr Rolfo, Dr Haanen )

The present and future agenda of SIOG

Prof Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore

The present and future agenda of SIOG ( Prof Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore )

SIOG 2020: Prostate task force and geriatric oncology during COVID 19

Prof Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore

SIOG 2020: Prostate task force and geriatric oncology during COVID 19 ( Prof Ravindran Kanesvaran - National Cancer Centre Singapore, Singapore )

More from ecancer